Cyclodextrin-assisted assembly of PEGylated polyester nanoparticles decorated with folate

Claudia Conte1, Iolanda Fotticchia1, Pasquale Tirino2

  • 1Department of Pharmacy, University of Napoli Federico II, Via Domenico Montesano 49, 80131 Napoli, Italy.

Insights

Researchers developed novel folate-targeted nanoparticles using poly(ε-caprolactone) (PCL) and polyethylene glycol (PEG) with (2-hydroxypropyl)-β-cyclodextrin (HPβCD). This strategy enhances folate presentation on nanoparticles, improving cancer cell targeting and uptake.

Area of Science:

  • Nanomedicine
  • Biomaterials Science
  • Oncology

Background:

  • Polyethylene glycol (PEG)-coated nano-oncologicals facilitate passive tumor targeting.
  • Folate-decorated nanocarriers improve cancer cell selectivity.
  • Effective folate display on nanoparticles is crucial for receptor binding and cellular uptake.

Purpose of the Study:

  • To develop a novel strategy for producing core-shell folate-targeted nanoparticles (NPs).
  • To investigate the role of (2-hydroxypropyl)-β-cyclodextrin (HPβCD) in enhancing folate presentation on NPs.
  • To improve the efficacy of folate-mediated cancer cell targeting.

Main Methods:

  • Synthesis and characterization of PCL-PEG and PCL-PEG-folate copolymers.
  • Production of NPs using a melting/sonication method with and without HPβCD.
  • Evaluation of colloidal properties, folate interaction, and cellular uptake of targeted NPs.

Main Results:

  • NPs produced with HPβCD exhibited extended polyethylene glycol (PEG) chain conformation.
  • Enhanced interaction with anti-folate antibodies was observed for HPβCD-modified NPs.
  • A higher uptake of targeted NPs was noted in cells overexpressing folate receptors.

Conclusions:

  • HPβCD aids in the effective display of folate on nanoparticle surfaces.
  • Manipulation of PEG shell conformation via HPβCD is a viable non-covalent strategy.
  • This approach offers a promising method for improving folate-targeted nanomedicine delivery.

Related Concept Videos